BRIEF-ProQR Therapeutics To Present Results From Phase 1/2 Trial Of Qr-421A For Usher Syndrome

Reuters · 03/17/2021 11:46
BRIEF-ProQR Therapeutics To Present Results From Phase 1/2 Trial Of Qr-421A For Usher Syndrome

- ProQR Therapeutics NV PRQR.O:

  • PROQR TO PRESENT RESULTS FROM PHASE 1/2 TRIAL OF QR-421A FOR USHER SYNDROME

Source text for Eikon: ID:nGNX9Sx8Xf

Further company coverage: PRQR.O


((Reuters.Briefs@thomsonreuters.com;))